-
2
-
-
0028989973
-
MUC-1 epithelial tumor mucin-based immunity and cancer vaccines
-
Finn OJ, Jerome KR, Henderson RA, et al. MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 1995; 145: 61-89.
-
(1995)
Immunol Rev
, vol.145
, pp. 61-89
-
-
Finn, O.J.1
Jerome, K.R.2
Henderson, R.A.3
-
3
-
-
0038012891
-
Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer
-
Croce MV, Isla Larrain MT, Rua CE, Rabassa ME, Gendler SJ, Segal-Eiras A. Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer. J Histochem Cytochem 2003; 51: 781-788.
-
(2003)
J Histochem Cytochem
, vol.51
, pp. 781-788
-
-
Croce, M.V.1
Isla, L.M.T.2
Rua, C.E.3
Rabassa, M.E.4
Gendler, S.J.5
Segal-Eiras, A.6
-
4
-
-
0343570538
-
MUC1: The polymorphic appearance of a human mucin
-
Hanisch FG, Müller S. MUC1: the polymorphic appearance of a human mucin. Glycobiology 2000; 10: 439-449.
-
(2000)
Glycobiology
, vol.10
, pp. 439-449
-
-
Hanisch, F.G.1
Müller, S.2
-
6
-
-
17344392248
-
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin
-
von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P, et al. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol 2000; 18: 574-583.
-
(2000)
J Clin Oncol
, vol.18
, pp. 574-583
-
-
von Mensdorff-Pouilly, S.1
Verstraeten, A.A.2
Kenemans, P.3
-
7
-
-
0037501163
-
The case for polyvalent cancer vaccines that induce antibodies
-
Ragupathi G, Livingston P. The case for polyvalent cancer vaccines that induce antibodies. Expert Rev Vaccines 2002; 1: 193-206.
-
(2002)
Expert Rev Vaccines
, vol.1
, pp. 193-206
-
-
Ragupathi, G.1
Livingston, P.2
-
8
-
-
84860390208
-
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis
-
Blixt O, Bueti D, Burford B, et al. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis. Breast Cancer Res 2011; 13: R25.
-
(2011)
Breast Cancer Res
, vol.13
-
-
Blixt, O.1
Bueti, D.2
Burford, B.3
-
9
-
-
0242267121
-
Tissue and serum MUC1 mucin detection in breast cancer patients
-
Croce MV, Isla Larrain MT, Demichelis SO, Gori JR, Price MR, Segal-Eiras A. Tissue and serum MUC1 mucin detection in breast cancer patients. Breast Cancer Res Treat 2003; 81: 195-207.
-
(2003)
Breast Cancer Res Treat
, vol.81
, pp. 195-207
-
-
Croce, M.V.1
Isla, L.M.T.2
Demichelis, S.O.3
Gori, J.R.4
Price, M.R.5
Segal-Eiras, A.6
-
10
-
-
0024353046
-
A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM3 is selectively exposed in a range of primary carcinomas
-
Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor- Papadimitriou J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM3 is selectively exposed in a range of primary carcinomas. Int J Cancer 1989; 43: 1072-1076.
-
(1989)
Int J Cancer
, vol.43
, pp. 1072-1076
-
-
Girling, A.1
Bartkova, J.2
Burchell, J.3
Gendler, S.4
Gillett, C.5
Taylor-Papadimitriou, J.6
-
11
-
-
0023617395
-
Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin
-
Burchell J, Gendler S, Taylor-Papadimitriou J, et al. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 1987; 47: 5476-5482.
-
(1987)
Cancer Res
, vol.47
, pp. 5476-5482
-
-
Burchell, J.1
Gendler, S.2
Taylor-Papadimitriou, J.3
-
12
-
-
33846496361
-
Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat
-
Tarp MA, Sørensen AL, Mandel U, et al. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat. Glycobiology 2007; 17: 197-209.
-
(2007)
Glycobiology
, vol.17
, pp. 197-209
-
-
Tarp, M.A.1
Sørensen, A.L.2
Mandel, U.3
-
13
-
-
68149166302
-
Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice
-
Ryan SO, Vlad AM, Islam K, Gariépy J, Finn OJ. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice. Biol Chem 2009; 390: 611-618.
-
(2009)
Biol Chem
, vol.390
, pp. 611-618
-
-
Ryan, S.O.1
Vlad, A.M.2
Islam, K.3
Gariépy, J.4
Finn, O.J.5
-
14
-
-
42049109699
-
MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1
-
Engelmann K, Shen H, Finn OJ. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res 2008; 68: 2419-2426.
-
(2008)
Cancer Res
, vol.68
, pp. 2419-2426
-
-
Engelmann, K.1
Shen, H.2
Finn, O.J.3
-
15
-
-
76749087478
-
Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes
-
Wandall HH, Blixt O, Tarp MA, et al. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res 2010; 70: 1306-13.
-
(2010)
Cancer Res
, vol.70
, pp. 1306-1313
-
-
Wandall, H.H.1
Blixt, O.2
Tarp, M.A.3
|